Breaking the Pharmaceutical Monopoly | Dan Liljenquist, CivicaRx; CSO, Intermountain Healthcare

In this episode, Gary speaks with Dan Liljenquist, Board Chair, CivicaRx, Chief Strategy Officer, Intermountain Healthcare, about the innovative idea of a non profit drug company. They discussed questions of regulation and distribution, and they spoke of the broader impact this new model will have on drug prices across the market.

For More Info about The Gary Bisbee Show Visit:

Dan Liljenquist is the lead architect and Board Chair of Civica Rx. His also Senior Vice President and
Chief Strategy Officer for Intermountain Healthcare, where he also oversees Intermountain’s
Enterprise Initiative and Market Intelligence & Planning Offices. Prior to Intermountain, Dan served
in the Utah State Senate. He is a former strategy consultant with Bain & Company, Inc. Dan received
a bachelor’s in Economics from Brigham Young University and a JD from The University of Chicago.